Acclaro Medical · 2 months ago
Revenue Account Manager
Acclaro Corporation is a pioneering medical technology company focused on developing game-changing solutions that address today's most challenging unmet needs in the global medical aesthetic market. The Revenue Accounting Manager will be responsible for establishing and managing revenue recognition policies, supporting contract reviews, and ensuring compliance with ASC 606 while collaborating with various teams to support revenue streams.
BeautyCosmetic SurgeryHealth CareMedical
Responsibilities
Develop and implement scalable revenue recognition processes tailored to startup operations
Review customer contracts and pricing models to ensure proper revenue treatment under ASC 606
Own the monthly revenue close process, including journal entries, reconciliations, and reporting
Collaborate with cross-functional teams to support new product launches and pricing strategies
Manage billing and collections, ensuring timely invoicing and cash application
Support the implementation of financial systems and automation tools
Prepare audit-ready documentation and support external audits
Monitor deferred revenue, rebates, and warranty obligations
Assist in financial forecasting and budgeting related to revenue
Qualification
Required
Bachelors degree in Accounting or Finance
5+ years of accounting experience, ideally with exposure to startups or high-growth environments
Strong understanding of ASC 606 and revenue accounting principles
Proficient with NetSuite and Excel
Ability to thrive in a fast-paced, ambiguous environment and build processes from scratch
Excellent communication and problem-solving skills
Preferred
CPA preferred
Familiarity with SaaS or subscription-based revenue models
Prior involvement in system implementations or scaling finance operations
Company
Acclaro Medical
Founded in 2018 by world-class industry experts and top physicians in the nation, Acclaro Corporation is a US-based, VC-backed, fast-growing medical device company committed to innovating and developing game-changing solutions to address today’s most challenging unmet needs in the global medical aesthetic, ophthalmic and surgical markets.
Funding
Current Stage
Growth StageTotal Funding
$23MKey Investors
Accelmed
2025-05-29Series B· $23M
Leadership Team
Recent News
Company data provided by crunchbase